20 /100
LOW RISK
Score updated May 30, 2026

IKT — Inhibikase Therapeutics, Inc. Dilution Risk Tracker

Track IKT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IKT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.79 approaching $1 threshold
🔔 Track IKT — Get forecast alerts →

💹 Market Data

Market Cap$231.06M
Shares Outstanding132.03M
Float86.88M
Cash$299.60M
Debt$381.8K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 108.1% shares (2025Q4 vs prior)
74 institutional holders · 114.61M shares
#1 ADAR1 Capital Management, LLC 16.13M shares
#2 Sands Capital Alternatives, LLC 13.02M shares
#3 Soleus Capital Management, L.P. 10.88M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest17.69M
Days to Cover26.5
% of Float20.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2023
xbrl XBRL CONVERTIBLE Dec 28, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track IKT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IKT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for IKT
📊 IKT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IKT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.